US Stock MarketDetailed Quotes

TXG 10x Genomics

Watchlist
  • 26.390
  • +1.030+4.06%
Close May 9 16:00 ET
  • 26.390
  • 0.0000.00%
Post 16:20 ET
3.16BMarket Cap-11781P/E (TTM)

10x Genomics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-281.21%-15.73M
54.78%-15.2M
87.70%25.76M
-164.58%-25.3M
32.05%-11.53M
80.17%-4.13M
-57.24%-33.61M
136.40%13.72M
63.52%-9.56M
-643.69%-16.96M
Net income from continuing operations
-18.13%-59.95M
-53.67%-255.1M
-184.36%-48.95M
-121.85%-92.99M
3.17%-62.41M
-19.65%-50.75M
-185.11%-166M
6.69%-17.22M
-144.10%-41.91M
-483.22%-64.46M
Operating gains losses
----
--1.72M
--3K
--0
--0
--1.72M
----
----
----
----
Depreciation and amortization
33.40%11.49M
32.15%43.62M
38.17%11.71M
40.73%11.42M
40.66%11.88M
8.04%8.62M
16.82%33.01M
15.67%8.47M
11.55%8.12M
17.49%8.44M
Other non cash items
196.00%444K
----
----
----
67.15%463K
-18.03%150K
----
----
----
--277K
Change In working capital
-5.65%-6.3M
144.00%17.34M
188.22%17.07M
262.69%16.17M
-503.62%-9.93M
52.68%-5.96M
54.92%-39.42M
-93.70%-19.35M
76.49%-9.94M
112.32%2.46M
-Change in receivables
-10.51%23.52M
43.99%-10.61M
46.78%-10.97M
-119.87%-16.17M
-3,383.84%-9.75M
201.09%26.28M
44.34%-18.95M
-202.14%-20.62M
62.09%-7.35M
118.17%297K
-Change in inventory
-2,113.14%-9.94M
137.14%7.87M
632.08%7.61M
129.65%2.57M
74.72%-1.86M
87.98%-449K
29.67%-21.19M
83.71%-1.43M
-21.39%-8.66M
-31.49%-7.37M
-Change in prepaid assets
52.29%-2.03M
45.96%-2.43M
159.72%1.22M
-152.68%-1.52M
244.41%2.13M
-9.81%-4.25M
-326.88%-4.5M
-1,320.36%-2.04M
2,027.33%2.89M
-386.96%-1.48M
-Change in payables and accrued expense
-758.92%-8.09M
142.38%22.28M
6,406.94%15.94M
25.63%4.53M
-54.21%2.75M
-41.44%-942K
127.07%9.19M
-56.64%245K
115.67%3.61M
137.96%6.01M
-Change in other current assets
102.06%216K
-173.30%-678K
-175.49%-388K
5,907.77%17.78M
-18,002.38%-7.6M
-6,768.79%-10.47M
-11.48%925K
-26.26%514K
125.95%296K
-180.77%-42K
-Change in other current liabilities
-32.49%-2.71M
21.12%-7.39M
-20.94%-2.17M
83.93%-923K
-34.19%-2.25M
-1,255.63%-2.05M
-30.54%-9.37M
-203.89%-1.8M
-738.33%-5.75M
33.64%-1.67M
-Change in other working capital
48.43%-7.26M
85.82%8.3M
0.78%5.83M
97.05%9.9M
-0.94%6.65M
-7.85%-14.08M
-75.02%4.46M
20.89%5.78M
-21.62%5.02M
33.41%6.71M
Cash from discontinued investing activities
Operating cash flow
-281.21%-15.73M
54.78%-15.2M
87.70%25.76M
-164.58%-25.3M
32.05%-11.53M
80.17%-4.13M
-57.24%-33.61M
136.40%13.72M
63.52%-9.56M
-643.69%-16.96M
Investing cash flow
Cash flow from continuing investing activities
-91.14%10.63M
138.04%133.49M
139.49%13.1M
115.02%4.9M
83.79%-4.46M
146.57%119.96M
-228.76%-350.89M
-20.11%-33.17M
-61.32%-32.63M
-88.96%-27.53M
Net PPE purchase and sale
36.17%-2.91M
63.09%-48.6M
91.32%-3.45M
58.34%-15.24M
6.84%-25.36M
83.80%-4.56M
-30.00%-131.66M
-43.87%-39.73M
-80.81%-36.57M
-86.84%-27.22M
Net intangibles purchase and sale
--0
---923K
--0
---200K
--0
---723K
--0
--0
--0
--0
Net business purchase and sale
----
--0
--0
----
----
----
26.62%-4M
---2.5M
----
----
Net investment purchase and sale
-89.19%13.54M
185.03%183.02M
82.61%16.55M
273.69%20.34M
6,883.77%20.89M
154.59%125.24M
---215.23M
--9.06M
--5.44M
---308K
Cash from discontinued investing activities
Investing cash flow
-91.14%10.63M
138.04%133.49M
139.49%13.1M
115.02%4.9M
83.79%-4.46M
146.57%119.96M
-228.76%-350.89M
-20.11%-33.17M
-61.32%-32.63M
-88.96%-27.53M
Financing cash flow
Cash flow from continuing financing activities
147.98%1.64M
-13.58%13.67M
12.24%5.61M
114.52%4.37M
11.57%7.1M
-241.25%-3.41M
-55.19%15.82M
-43.83%5M
-69.49%2.04M
-60.72%6.36M
Proceeds from stock option exercised by employees
-31.75%1.64M
-8.21%19.48M
12.24%5.61M
114.52%4.37M
11.57%7.1M
-69.33%2.4M
-47.36%21.23M
-43.83%5M
-69.49%2.04M
-60.72%6.36M
Net other financing activities
----
-7.49%-5.81M
--0
--0
--0
-7.49%-5.81M
-7.58%-5.41M
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
147.98%1.64M
-13.58%13.67M
12.24%5.61M
114.52%4.37M
11.57%7.1M
-241.25%-3.41M
-55.19%15.82M
-43.83%5M
-69.49%2.04M
-60.72%6.36M
Net cash flow
Beginning cash position
58.03%359.28M
-61.86%227.35M
30.30%314.74M
17.41%330.85M
6.15%339.79M
-61.86%227.35M
-13.44%596.07M
-60.34%241.55M
-56.56%281.79M
-50.29%320.11M
Current changes in cash
-103.07%-3.46M
135.79%131.96M
407.79%44.47M
60.08%-16.03M
76.68%-8.89M
140.74%112.42M
-297.26%-368.68M
-11.91%-14.45M
-0.99%-40.16M
-903.58%-38.13M
Effect of exchange rate changes
-300.00%-48K
25.00%-33K
-69.32%77K
0.00%-85K
74.48%-49K
233.33%24K
-118.80%-44K
406.10%251K
-172.65%-85K
-3,300.00%-192K
End cash Position
4.70%355.78M
58.03%359.28M
58.03%359.28M
30.30%314.74M
17.41%330.85M
6.15%339.79M
-61.86%227.35M
-61.86%227.35M
-60.34%241.55M
-56.56%281.79M
Free cash flow
-98.10%-18.64M
60.84%-64.72M
185.76%22.31M
11.70%-40.74M
16.52%-36.88M
80.78%-9.41M
-34.75%-165.27M
-19.25%-26.01M
0.66%-46.14M
-285.94%-44.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -281.21%-15.73M54.78%-15.2M87.70%25.76M-164.58%-25.3M32.05%-11.53M80.17%-4.13M-57.24%-33.61M136.40%13.72M63.52%-9.56M-643.69%-16.96M
Net income from continuing operations -18.13%-59.95M-53.67%-255.1M-184.36%-48.95M-121.85%-92.99M3.17%-62.41M-19.65%-50.75M-185.11%-166M6.69%-17.22M-144.10%-41.91M-483.22%-64.46M
Operating gains losses ------1.72M--3K--0--0--1.72M----------------
Depreciation and amortization 33.40%11.49M32.15%43.62M38.17%11.71M40.73%11.42M40.66%11.88M8.04%8.62M16.82%33.01M15.67%8.47M11.55%8.12M17.49%8.44M
Other non cash items 196.00%444K------------67.15%463K-18.03%150K--------------277K
Change In working capital -5.65%-6.3M144.00%17.34M188.22%17.07M262.69%16.17M-503.62%-9.93M52.68%-5.96M54.92%-39.42M-93.70%-19.35M76.49%-9.94M112.32%2.46M
-Change in receivables -10.51%23.52M43.99%-10.61M46.78%-10.97M-119.87%-16.17M-3,383.84%-9.75M201.09%26.28M44.34%-18.95M-202.14%-20.62M62.09%-7.35M118.17%297K
-Change in inventory -2,113.14%-9.94M137.14%7.87M632.08%7.61M129.65%2.57M74.72%-1.86M87.98%-449K29.67%-21.19M83.71%-1.43M-21.39%-8.66M-31.49%-7.37M
-Change in prepaid assets 52.29%-2.03M45.96%-2.43M159.72%1.22M-152.68%-1.52M244.41%2.13M-9.81%-4.25M-326.88%-4.5M-1,320.36%-2.04M2,027.33%2.89M-386.96%-1.48M
-Change in payables and accrued expense -758.92%-8.09M142.38%22.28M6,406.94%15.94M25.63%4.53M-54.21%2.75M-41.44%-942K127.07%9.19M-56.64%245K115.67%3.61M137.96%6.01M
-Change in other current assets 102.06%216K-173.30%-678K-175.49%-388K5,907.77%17.78M-18,002.38%-7.6M-6,768.79%-10.47M-11.48%925K-26.26%514K125.95%296K-180.77%-42K
-Change in other current liabilities -32.49%-2.71M21.12%-7.39M-20.94%-2.17M83.93%-923K-34.19%-2.25M-1,255.63%-2.05M-30.54%-9.37M-203.89%-1.8M-738.33%-5.75M33.64%-1.67M
-Change in other working capital 48.43%-7.26M85.82%8.3M0.78%5.83M97.05%9.9M-0.94%6.65M-7.85%-14.08M-75.02%4.46M20.89%5.78M-21.62%5.02M33.41%6.71M
Cash from discontinued investing activities
Operating cash flow -281.21%-15.73M54.78%-15.2M87.70%25.76M-164.58%-25.3M32.05%-11.53M80.17%-4.13M-57.24%-33.61M136.40%13.72M63.52%-9.56M-643.69%-16.96M
Investing cash flow
Cash flow from continuing investing activities -91.14%10.63M138.04%133.49M139.49%13.1M115.02%4.9M83.79%-4.46M146.57%119.96M-228.76%-350.89M-20.11%-33.17M-61.32%-32.63M-88.96%-27.53M
Net PPE purchase and sale 36.17%-2.91M63.09%-48.6M91.32%-3.45M58.34%-15.24M6.84%-25.36M83.80%-4.56M-30.00%-131.66M-43.87%-39.73M-80.81%-36.57M-86.84%-27.22M
Net intangibles purchase and sale --0---923K--0---200K--0---723K--0--0--0--0
Net business purchase and sale ------0--0------------26.62%-4M---2.5M--------
Net investment purchase and sale -89.19%13.54M185.03%183.02M82.61%16.55M273.69%20.34M6,883.77%20.89M154.59%125.24M---215.23M--9.06M--5.44M---308K
Cash from discontinued investing activities
Investing cash flow -91.14%10.63M138.04%133.49M139.49%13.1M115.02%4.9M83.79%-4.46M146.57%119.96M-228.76%-350.89M-20.11%-33.17M-61.32%-32.63M-88.96%-27.53M
Financing cash flow
Cash flow from continuing financing activities 147.98%1.64M-13.58%13.67M12.24%5.61M114.52%4.37M11.57%7.1M-241.25%-3.41M-55.19%15.82M-43.83%5M-69.49%2.04M-60.72%6.36M
Proceeds from stock option exercised by employees -31.75%1.64M-8.21%19.48M12.24%5.61M114.52%4.37M11.57%7.1M-69.33%2.4M-47.36%21.23M-43.83%5M-69.49%2.04M-60.72%6.36M
Net other financing activities -----7.49%-5.81M--0--0--0-7.49%-5.81M-7.58%-5.41M--0--0--0
Cash from discontinued financing activities
Financing cash flow 147.98%1.64M-13.58%13.67M12.24%5.61M114.52%4.37M11.57%7.1M-241.25%-3.41M-55.19%15.82M-43.83%5M-69.49%2.04M-60.72%6.36M
Net cash flow
Beginning cash position 58.03%359.28M-61.86%227.35M30.30%314.74M17.41%330.85M6.15%339.79M-61.86%227.35M-13.44%596.07M-60.34%241.55M-56.56%281.79M-50.29%320.11M
Current changes in cash -103.07%-3.46M135.79%131.96M407.79%44.47M60.08%-16.03M76.68%-8.89M140.74%112.42M-297.26%-368.68M-11.91%-14.45M-0.99%-40.16M-903.58%-38.13M
Effect of exchange rate changes -300.00%-48K25.00%-33K-69.32%77K0.00%-85K74.48%-49K233.33%24K-118.80%-44K406.10%251K-172.65%-85K-3,300.00%-192K
End cash Position 4.70%355.78M58.03%359.28M58.03%359.28M30.30%314.74M17.41%330.85M6.15%339.79M-61.86%227.35M-61.86%227.35M-60.34%241.55M-56.56%281.79M
Free cash flow -98.10%-18.64M60.84%-64.72M185.76%22.31M11.70%-40.74M16.52%-36.88M80.78%-9.41M-34.75%-165.27M-19.25%-26.01M0.66%-46.14M-285.94%-44.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg